Paul Begovac
11Patents
5h-index
14Co-inventors
63Inventor score
Filing activity: Apr 22, 1980 → Jun 26, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5908449A | Blood contact surfaces using extracellular matrix synthesized in vitro | Emerging Cross-Sectional Technologies | 134 | Expired |
| US5879383A | Blood contact surfaces using endothelium on a subendothelial matrix | Human Necessities | 68 | Expired |
| US4321914A | Percutaneous conduit having PTFE skirt | Human Necessities | 63 | Expired |
| US5716394A | Blood contact surfaces using extracellular matrix synthesized in vitro | Emerging Cross-Sectional Technologies | 21 | Expired |
| US9101696B2 | Immobilised biological entities | Emerging Cross-Sectional Technologies | 17 | Active |
| US9005269B2 | Bioabsorbable self-expanding endolumenal devices | Human Necessities | 3 | Active |
| US9764068B2 | Immobilised biological entities | Emerging Cross-Sectional Technologies | 2 | Active |
| US9408950B2 | Immobilised biological entities | Emerging Cross-Sectional Technologies | 1 | Active |
| US10736999B2 | Immobilised biological entities | Emerging Cross-Sectional Technologies | 1 | Active |
| US11752099B2 | Injectable and biodegradable polymer formulations for controlled release of bioactive agents | Chemistry; Metallurgy | 0 | Active |
| US11497838B2 | Immobilised biological entities | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.